VSEE HEALTH, INC. (VSEE) Form 10-Q — Nov 16, 2026
VSee Health filed its Q3 2026 10-Q with revenue of $4.94 million for the nine months (up from $4.57 million), but a Q3 loss from continuing operations of $2.85 million versus only $42,456 a year earlier. Cash ended the period at just $41,666 against $9.6 million in current liabilities, and management explicitly raised substantial doubt about the company's ability to continue as a going concern. The company executed a 1-for-80 reverse stock split on September 22, 2026, a dilutive last-resort measure typically tied to listing/price compliance. Multiple legacy notes payable remain in default for late payment, with default interest rates of up to 26% per annum accruing on several.
Key figures
- Eps
- -6.83
- Revenue
- 4937956
- Total Debt
- 1813998
- Revenue Yoy
- 9-month revenue up from $4,571,727 in prior-year period
- Total Assets
- 15706172
- Cash Position
- 41666
- Q3 revenue
- 1496779
- Accumulated deficit
- 87018413
- Reverse split ratio
- 1:80
- Shares outstanding nov15 2026
- 876837
- Gain on sale of discontinued ops
- 4168878
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.